CClinicalTrials.gg
CompletedNCT03259646Updated Jan 18, 2020

The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women

An interventional study of Universal Education in Violence, Domestic and Violence, Sexual, sponsored by Johns Hopkins University. Completed at 9 sites in United States. Open to female participants aged 18 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-18.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
6,272
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
Female
01

Study summary

Violence against women is a major public health threat that carries significant consequences for women's health. Moreover, women experiencing intimate partner violence (IPV) and sexual assault (SA) are more likely than non-abused women to seek certain forms of health services, such as for sexually transmitted infections, chronic pain and illnesses, depression and/or pregnancy-related concerns. As a result, the health sector is an ideal setting to identify and support survivors. The U.S. Institute of Medicine has identified the health care system, including the public health infrastructure, as key for identification of and support for survivors of violence, as well as for violence prevention. While some evidence-based models exist, no current national consensus has been reached on scalable best practices in screening and brief counseling for IPV/SA.

This multi-level intervention includes integrating into the clinic setting IPV/SA screening, universal education, trauma informed counseling, warm referrals (e.g. provider/staff contact advocacy program with survivor) to local IPV/SA advocacy agencies, and access to the evidence-based myPlan safety decision aid app. The evaluation, using a cluster randomized trial design, will measure longitudinal outcomes (over 6 months) of patient self-efficacy, health and safety outcomes, as well as participant and provider perceptions of the intervention and clinic level changes in primary and reproductive health clinics in four states (Arizona, Massachusetts, Pennsylvania and West Virginia) to achieve the following aims:

Aim 1. Evaluate the effectiveness of an evidence-based screening, universal education and trauma-informed counseling with tailored safety action plan and referrals to partner IPV/SA programs compared to standard practice, on survivor health and safety outcomes over a cumulative period of six months.

Aim 2. Examine longitudinal changes in clinic-level screening, universal education, trauma informed counseling, safety action plans and referrals to on-site and/or partner IPV/SA programs and improved standards for documentation through the electronic health record (EHR) and continuous quality measurement and reporting.

02

Conditions studied

  • Violence, Domestic
  • Violence, Sexual
03

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Seeking healthcare at one of 14 partner clinics
  • Ability to complete a survey on a device (computer/tablet/smartphone in English or Spanish)
  • Access to safe device (as defined above) if doing surveys online
  • Has a safe email address or safe phone number
  • Is not acutely ill

Exclusion criteria

Exclusion Criteria:

  • Male
  • Not seeking healthcare at one of 9 partner clinics
  • Younger than 18 years of age
  • Older than 59 years of age
  • Cannot read/speak English or Spanish
  • No access to safe device if doing surveys online
  • Does not have a safe email address or safe phone number
  • Acutely ill
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
6,272 participants (actual)

Study arms

  • Experimental
    Universal Education

    Train providers to integrate screening, universal education, trauma informed counseling, and mobile health (mHealth) technology through the myPlan app safety decision aid in collaboration with local IPV programs as well as the integration of documentation and quality improvement templates and measures into clinical settings.

    Behavioral: Universal Education

  • No intervention
    Standard Practice

    Standard clinical practice

Interventions

  • BehavioralUniversal Education

    Clinic provider/staff training on implementing universal education into clinical practice to: 1.) provide all women information about IPV/SA, harm reduction, and available safety resources; 2) provide trauma-informed counseling to women who disclose IPV/SA; includes access to the myPlan safety decision aid to develop a tailored safety action plan; 3) provide warm referrals in partnership with local domestic violence and sexual assault (DV/SA) advocacy agencies; 4) integrate documentation and quality improvement templates and measures into clinical settings.

05

What researchers measure

Primary outcomes

  1. Change in use of safety behaviors

    Measured by percent of safety behaviors the woman has tried and found helpful on the Safety Behaviors Checklist. The checklist was adapted from Sullivan and colleagues and Parker and colleagues. Includes use of community resources and safety steps (e.g. asked for help, hidden emergency money) and use of formal services (e.g., women's shelter, protection order, mental health services).

    Time frame: 6 months

  2. Change in Self-Efficacy to Use Harm Reduction Strategies

    Measure adapted from Tancredi et al and Hibbard et al, assesses confidence to seek help for abuse, if needed, from a health care provider.

    Time frame: 6 months

  3. Provider Behavior

    Clinic level measure. Provider Behavior at Visit Survey items administered after the provider visit to assess the provider's adherence to universal education intervention, i.e. discussing healthy and unhealthy relationships during the visit, and referring to resources.

    Time frame: Baseline

Secondary outcomes

  1. Change in decisional conflict

    We have adapted questions from validated subscales of the Decisional Conflict Scale as a measure of decision process. Measures whether the intervention helps a woman to understand the advantages and disadvantages of safety planning options and to know her values related to them. The Decisional Conflict Scale discriminates between people who make decisions and those who delay making decisions.

    Time frame: 6 months

  2. Change in Readiness to Take Action

    0-10 scale of readiness to make changes to relationship for safety

    Time frame: 6 months

06

Study locations

9 sites
  • North County HealthCare
    Kingman, Arizona 86401, United States
  • North Country HealthCare
    Lake Havasu City, Arizona 86403, United States
  • North Country HealthCare
    Williams, Arizona 86046, United States
  • Partners Health Care Brigham and Women's Hospital
    Boston, Massachusetts 02115, United States
  • Magee-Women's Hospital of UPMC
    Pittsburgh, Pennsylvania 15213, United States
  • Women's Health Center
    Charleston, West Virginia 25302, United States
  • Valley Health
    Mill Creek, West Virginia 26280, United States
  • Greenbrier Co. Health Dept
    Ronceverte, West Virginia 24970, United States
  • FamilyCare Health Center
    Scott Depot, West Virginia 25560, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03259646
Lead sponsor
Johns Hopkins University
Collaborators
Office of Research on Women's Health (ORWH), University of Pittsburgh, Futures Without Violence
Responsible party
Sponsor
First posted
Aug 24, 2017
Start date
May 26, 2017
Primary completion
Apr 25, 2019
Completion
Apr 25, 2019
Last update
Jan 18, 2020

Study contacts

Nancy Glass, PhD, MPH, RN
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion